ClinicalTrials.gg
RecruitingNCT07313345PrePOSEUpdated Dec 31, 2025

Predicting the Pain Outcome of Surgery for Endometriosis

An observational study in Endometriosis, sponsored by University of Oxford. Recruiting at 1 site in United Kingdom. Open to female participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2025-12-31.

Sponsored by University of Oxford · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
18 Years to 50 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 25 studies in Endometriosis with a site in United Kingdom — 10 open to participants now, 11 under way, none of them phase 3. Endometriosis · United Kingdom.

Planned enrollment
6th of 12
100 · median 100
Started
2025
with 5 others
Observational
12 of 25
8 open now
Primary completion
2028-08
later than 8 of 10 live
Registered
23rd of 25
by date
Lead sponsor
3 of 25
University of Oxford

Among the 25 studies in Endometriosis with a site in United Kingdom, this one is the 6th largest by planned enrollment of the 12 observational ones that give a count, is one of 6 that started in 2025, is one of 12 observational ones, reaches primary completion later than 8 of the 10 other live ones, and was the 23rd registered.

Endometriosis

924 studies on the registry are indexed under Endometriosis; 268 are open to participants now.

Browse Endometriosis studies →

Open to participants now

10 of the 25 studies in Endometriosis with a site in United Kingdom are open now. Recruiting first, the newest first:

4 more — sign in →

All 10 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 180 Endometriosis studies recruiting now, 53 (29%) set no upper age limit and 125 (69%) stop at 75 or younger; 18 take children under 18; 39 take healthy volunteers.

This study: 18 Years to 50 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 25 studies in Endometriosis with a site in United Kingdom, or all of them as a file.
02

Study summary

This study aims to determine whether the investigators can predict who will get benefit in terms of their pain from surgery for more severe forms of endometriosis. The investigators will use brain imaging to explore this, as it allows meaningful results from a smaller sample of people than if questionnaires alone were relied on.

Read the detailed description

Endometriosis is a chronic gynaecological condition that affects around 10% of women of reproductive age. This condition can cause debilitating pain, infertility, and poor quality of life. Endometriosis is a condition where tissue resembling the womb lining is present outside of the womb and is associated with an inflammatory pelvic environment. Symptoms of endometriosis can consist of pain during periods, chronic (non-cyclical) pelvic pain, pain during sex, pain when urinating, pain when defecating, and fatigue. Current treatments for endometriosis consist of hormonal, anti-inflammatory and / or analgesic medications and surgery, which is usually laparoscopic ("key-hole"). However, surgery does not always result in a reduction in pain for patients with endometriosis, therefore, it is important to try and understand which patients are most likely to benefit from surgery for their pain management.

Endometriosis is categorized into 4 stages (I - IV), ranging from small areas of tissue that do not extend deeply (stage I) to deep lesions associated with significant scarring of the pelvis and ovarian cysts (endometriomas). Interestingly, symptoms do not correlate with stage of disease. An NIHR funded clinical trial is currently investigating whether surgical treatment of superficial peritoneal endometriosis is of clinical benefit (ESPriT2) and is expected to report early in 2026 (recruitment and baseline data collection are complete). However, women with more severe forms of the disease are excluded from this trial. Surgery is commonly recommended for those with more extensive disease (stages III and IV), however, the risks of surgery are considerably greater for these patients including risk of bladder and bowel damage (sometimes requiring stoma formation) and a negative impact on future fertility. Therefore it is important to better understand who will benefit from this type of surgery. Rather than performing a full clinical trial, the investigators will use a set of experimental tests that allow pain to be understood in more detail meaning less people need to be included in the study and results will be available sooner.

In the present study, patients with pelvic endometriosis at stage III or IV with planned surgical treatment scheduled will be recruited to the project. Participants taking part will provide data at 5 different time points: Time point 1 will consist of several baseline questionnaires, an experimental sensory assessment, and a brain functional magnetic resonance imaging (fMRI) scan. Time point 2 will be the date of their endometriosis surgery, where a questionnaire will be taken, the surgery will be completed, and several biological samples (e.g. blood and small amounts of pelvic fluid and tissue) will be taken. Time points 3 (3 months post-surgery), 4 (6 months post-surgery), and 5 (12 months post-surgery) will consist of completing online questionnaires. All data collected within this project will be used to investigate pain outcome following endometriosis surgery. This research is funded by NIHR BRC.

03

Conditions studied

  • Endometriosis

Keywords

  • pelvic pain
  • fMRI
  • PROMs
04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients on the waiting list for surgery for severe endometriosis at the Oxford University Hospitals NHS Trust

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • willing and able to give
  • aged between 18 and 50 years of age
  • female or born female
  • diagnosed with stage III or IV endometriosis by scan (MRI or USS) or previous surgery
  • surgical treatment of severe endometriosis planned (surgical procedure at discretion of operating surgeon)
  • reports pelvic pain of ≥4/10 (measured using a 0 - 10 numerical rating scale asking about the participant's worst pelvic pain associated with their endometriosis)
  • reasonably fluent in English
  • in the Investigator's opinion, is able and willing to comply with all study requirements
  • willing to allow his or her General Practitioner and consultant to be notified of participation in the study

Exclusion criteria

Exclusion Criteria:

  • pregnant, lactating or planning pregnancy during the course of the study
  • to MRI
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • PrePOSE cohort

    Women aged 18 - 50 years, with stage III or IV endometriosis, reporting pelvic pain of ≥4/10 and planned for surgical treatment of their endometriosis

    Procedure: Surgical treatment of endometriosis

Interventions

  • ProcedureSurgical treatment of endometriosis

    This is an observational study and thus the surgery performed is part of standard clinical care. The procedure will be at the discretion of the operating surgeon/endometriosis multi-disciplinary team and may include bowel resection, stoma formation, ureteric stenting/reimplantation, salpingectomy, oophorectomy or hysterectomy in addition to excision/ablation of endometriosis lesions. Information about the surgical procedure will be collected, but no planned surgical procedure will be an exclusion.

06

What researchers measure

Primary outcomes

  1. Brain response to punctate stimulation of the calf

    BOLD (Blood oxygen level dependent) response measured with fMRI. Analysis will determine whether BOLD response prior to surgery can predict the pain response (at 12 months post-surgery) to surgical treatment of severe endometriosis.

    Time frame: prior to surgery

Secondary outcomes

  1. Brain connectivity at rest

    Resting state connectivity measured with fMRI

    Time frame: prior to surgery

  2. Brain volume

    Brain volume measured with MRI

    Time frame: prior to surgery

  3. Non-cyclical pelvic pain measured on an 11 point numerical rating scale (NRS)

    NRS anchored with 0=no pain, 10=worst pain imaginable

    Time frame: prior to surgery and at 12 months post-surgery

  4. Pain widespreadness

    Measured with the Michigan Body Map. The higher the score the more widespread the pain.

    Time frame: Prior to surgery

  5. Neuropathic-like pain

    Measured with the painDETECT scale. Scores range from -1 to 38. Higher scores represent more likely to have a neuropathic component to pain.

    Time frame: prior to surgery

  6. Pain catastrophising

    Measured with the pain catastrophising scale (Sullivan). Scores range from 0 - 52 with high scores representing higher levels of pain catastrophising. Although three sub scales exist they will not be assessed for the purposes of these main analyses.

    Time frame: Prior to surgery

  7. Pain self-efficacy

    Measured with the pain self-efficacy scale. Scores range from 0 to 60, with higher scores indicating greater confidence in managing pain.

    Time frame: Prior to surgery

  8. Expectation of surgical efficacy

    Measured on an 8 point verbal rating scale anchored with 0=I do not suffer from this and do not expect that will change, 1=very marked improvement, 2=marked improvement, 3=minimal improvement, 4=no change, 5=minimal worsening, 6=marked worsening, 7=very marked worsening

    Time frame: Prior to surgery

Other outcomes

  1. Quantitative Sensory Testing (QST) of the lower abdomen and left hand according to the German Neuropathic Pain Network Protocol

    Individual measures and the overall sensory profile cluster (derived according to Vollert)

    Time frame: Prior to surgery

07

Study locations

1 of 1 sites recruiting
  • Oxford University Hospitals Foundation Trust
    Oxford, Oxfordshire OX3 9DU, United Kingdom
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Once data analysis is complete all data will be deposited in appropriate publicly accessible repositories as required by the funders. No personal data will be included in these datasets.

Supporting information: Study protocol, Statistical analysis plan

Time frame: After publication of all manuscripts from the study

Access criteria: Data will be publicly accessible

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2025; primary completion for Aug 2028, 32 months later.

Of 158 non-industry observational studies under Endometriosis, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 48. This study's planned 32 months is close to that.

Counting every sponsor, half of 185 studies reached it within 30 months; a quarter within 14 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 20, 2025
First posted
Dec 31, 2025
StartEst.
Dec 2025
Primary completionEst.
Aug 2028
CompletionEst.
Aug 2028
Last update
Dec 31, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 31, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07313345
Collaborators
Endometriosis UK
Responsible party
Sponsor
First posted
Dec 31, 2025
Start date
Dec 2025 (estimated)
Primary completion
Aug 2028 (estimated)
Completion
Aug 2028 (estimated)
Last update
Dec 31, 2025

Study contacts

Katy Vincent, DPhil, FRCOG
Contact
katy.vincent@wrh.ox.ac.uk
00 44 1865 220024 ext. 01865220024
Kirralise Hansford, PhD
Contact
kirralise.hansford@wrh.ox.ac.uk
Katy Vincent
principal investigator · University of Oxford

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion